Patents by Inventor Gary Hoel

Gary Hoel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FORMULATIONS AND METHODS FOR PROVIDING PROGESTIN-ONLY CONTRACEPTION
    Publication number: 20220117977
    Abstract: Formulations and methods for providing progestin-only contraception to a woman including transdermally administering to a woman a formulation having a contraceptively effective amount of progestin-only hormonal agents as part of a contraceptive regimen.
    Type: Application
    Filed: December 29, 2021
    Publication date: April 21, 2022
    Applicant: ALLERGAN SALES, LLC
    Inventors: Charles Ebert, Gary Hoel, Angela Anigbogu, Samir Roy
  • FORMULATIONS AND METHODS FOR PROVIDING PROGESTIN-ONLY CONTRACEPTION WHILE MINIMIZING ADVERSE SIDE EFFECTS ASSOCIATED THEREWITH
    Publication number: 20200061082
    Abstract: Formulations and methods for providing progestin-only contraception to a woman including transdermally administering to a woman a formulation having a contraceptively effective amount of progestin-only hormonal agents as part of a contraceptive regimen.
    Type: Application
    Filed: November 1, 2019
    Publication date: February 27, 2020
    Applicant: ALLERGAN SALES, LLC
    Inventors: Charles Ebert, Gary Hoel, Angela Anigbogu, Samir Roy
  • Formulations and methods for providing progestin-only contraception while minimizing adverse side effects associated therewith
    Patent number: 10500215
    Abstract: Formulations and methods for providing progestin-only contraception to a woman while minimizing various side effects, such as breakthrough bleeding, that are normally associated with progestin-only contraception are disclosed and described. In one aspect, the method can include transdermally administering a formulation having a contraceptively effective amount of a single progestin as the sole active hormonal agent to the woman as part of a contraceptive regimen.
    Type: Grant
    Filed: October 17, 2018
    Date of Patent: December 10, 2019
    Assignee: Allergan Sales, LLC
    Inventors: Charles Ebert, Gary Hoel, Angela Anigbogu, Samir Roy
  • FORMULATIONS AND METHODS FOR PROVIDING PROGESTIN-ONLY CONTRACEPTION WHILE MINIMIZING ADVERSE SIDE EFFECTS ASSOCIATED THEREWITH
    Publication number: 20190111063
    Abstract: Formulations and methods for providing progestin-only contraception to a woman while minimizing various side effects, such as breakthrough bleeding, that are normally associated with progestin-only contraception are disclosed and described. In one aspect, the method can include transdermally administering a formulation having a contraceptively effective amount of a single progestin as the sole active hormonal agent to the woman as part of a contraceptive regimen.
    Type: Application
    Filed: October 17, 2018
    Publication date: April 18, 2019
    Inventors: Charles Ebert, Gary Hoel, Angela Anigbogu, Samir Roy
  • Formulations and methods for providing progestin-only contraception while minimizing adverse side effects associated therewith
    Patent number: 10137135
    Abstract: Formulations and methods for providing progestin-only contraception to a woman while minimizing various side effects, such as breakthrough bleeding, that are normally associated with progestin-only contraception are disclosed and described. In one aspect, the method can include transdermally administering a formulation having a contraceptively effective amount of a single progestin as the sole active hormonal agent to the woman as part of a contraceptive regimen.
    Type: Grant
    Filed: August 15, 2005
    Date of Patent: November 27, 2018
    Assignee: Allergan Sales, LLC
    Inventors: Charles Ebert, Gary Hoel, Angela Anigbogu, Samir Roy
  • METHODS FOR TREATING PROSTATITIS
    Publication number: 20120184591
    Abstract: It has been discovered that silodosin is effective in treating patients having symptoms associated with prostatitis with silodosin or a pharmaceutically acceptable salt thereof. In a preferred embodiment, patients are treated with 4 mg once daily.
    Type: Application
    Filed: February 23, 2011
    Publication date: July 19, 2012
    Applicant: WATSON PHARMACEUTICALS, INC.
    Inventors: Gary HOEL, Lawrence HILL, Kim CARAMELLI
  • Formulations and methods for providing progestin-only contraception while minimizing adverse side effects associated therewith
    Publication number: 20070037780
    Abstract: Formulations and methods for providing progestin-only contraception to a woman while minimizing various side effects, such as breakthrough bleeding, that are normally associated with progestin-only contraception are disclosed and described. In one aspect, the method can include transdermally administering a formulation having a contraceptively effective amount of a single progestin as the sole active hormonal agent to the woman as part of a contraceptive regimen.
    Type: Application
    Filed: August 15, 2005
    Publication date: February 15, 2007
    Inventors: Charles Ebert, Gary Hoel, Angela Anigbogu, Samir Roy